Non-invasive prenatal testing (NIPT) is a simple blood test which analyses fetal DNA in a pregnant woman. From 2018, the NHS will offer the test for high-risk pregnancies at nine weeks to screen for Down's syndrome and other conditions (see BioNews 876).
Professor Tom Shakespeare of University of East Anglia, chair of the Council's Working Group on NIPT, said: 'We support the introduction of this test for Down's syndrome on the NHS next year, so long as it is accompanied by good balanced information and support. But, if the test is used without limits for other kinds of genetic conditions and traits, it could lead to more anxiety, more invasive diagnostic tests, and could change what we think of as a healthy or normal baby.'
The report also cites the right of a future child to find out their own genome for themselves.
'That's why we are calling for a moratorium on its use in sequencing the whole genome of the fetus. We also strongly believe there should be a ban on its use to find out the sex of the fetus, as this could lead to sex-selective abortions,' said Professor Shakespeare.
The council recommends that NIPT should generally only be used to find significant medical conditions that would affect a baby at birth or in childhood. They also warned that many clinics which offer genome sequencing are unable to properly explain the significance of the information provided by the tests.
Dr Louise Bryant of the University of Leeds and a member of the Council's Working Group on NIPT, said: 'The information currently provided to women and couples by the private sector is frequently incomplete, unsubstantiated, inaccurate or misleading, and sometimes uses emotive language.'
'Parents should also be provided with an up-to-date picture of what life is like for people with the condition,' said Dr Bryant. 'In some cases it can have minor effects on people's lives, whilst in others the effects are more significant. Women and couples must get balanced information and support to help them make decisions that are right for them.'
Other experts have deemed the Nuffield Council's report as 'poor quality' and 'disappointing'.
'The proposed restriction to neonatal and childhood onset conditions excludes conditions such as early-onset dementia and neuromuscular disorders, which can be extremely serious and can cause enormous amounts of pain to families,' said Mr Alastair Kent, Director of Genetic Alliance UK.
The British Pregnancy Advisory Service said the report 'seems permeated by a mistrust of women and the reproductive choices they make'.
NIPT is already given by the NHS to women at high-risk of passing on genetic conditions, such as cystic fibrosis. The introduction of NIPT next year to estimate the chance of Down's syndrome should mean fewer false results and less invasive diagnostic testing, which carries a small risk of miscarriage.